Pitcairn’s Exelixis EXEL Stock Holding History

Pitcairn’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,584	Closed	-$245K	–	635
2021 Q3	$245K	Buy	11,584 +659	+6%	+$12.2K	0.02%	563
2021 Q2	$199K	Buy	+10,925	New	+$255K	0.01%	598

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pitcairn's EXEL Position: Q4 2021 in Review

Pitcairn sold out of Exelixis (EXEL) in Q4 2021, closing a stake of 11,584 shares — an estimated $245K sold.

Pitcairn first reported a position in EXEL in Q2 2021 and held it in 2 quarters. The position peaked at $245K in Q3 2021. 328 funds tracked by Wall St. Rank hold EXEL as of Q4 2021.

Pitcairn reported no remaining Exelixis position as of Q4 2021 after selling out during the quarter.
Pitcairn sold 11,584 Exelixis shares in Q4 2021, an estimated $245K.
Pitcairn first reported a position in Exelixis in Q2 2021 and held it in 2 quarters.
Pitcairn's Exelixis position peaked at $245K in Q3 2021.
328 funds tracked by Wall St. Rank held Exelixis as of Q4 2021.

Based on Pitcairn's 13F filing for Q4 2021, filed 14 Feb 2022.